Experience

Monument Biosciences

• United States
• Biotechnology Research
• 1 - 100 Employee

• Founder

  • Oct 2022 - Present

  Bringing forward the next generation of disease modifying drugs for Alzheimer’s Disease and Related Dementias (ADRD). Bringing forward the next generation of disease modifying drugs for Alzheimer’s Disease and Related Dementias (ADRD).



Indiana Biosciences Research Institute

• United States
• Research Services
• 1 - 100 Employee

• Scientific Director of Molecular Innovation

  • Feb 2021 - Present

  Collaborating with institute scientists, academics, and external research partners to drive translational science that rapidly advances novel therapeutics for unmet medical needs. Collaborating with institute scientists, academics, and external research partners to drive translational science that rapidly advances novel therapeutics for unmet medical needs.



Indiana University School of Medicine

• Research Services
• 700 & Above Employee

• Senior Research Professor

  • Apr 2020 - Present

  Division of Clinical Pharmacology, Department of Medicine Medicinal Chemistry Core leader for the IUSM-Purdue TREAT-AD Center Adjunct, Department of Pharmacology and Toxicology Affiliate, Stark Neurosciences Research Institute Division of Clinical Pharmacology, Department of Medicine Medicinal Chemistry Core leader for the IUSM-Purdue TREAT-AD Center Adjunct, Department of Pharmacology and Toxicology Affiliate, Stark Neurosciences Research Institute



Eli Lilly and Company

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Research Fellow

  • Oct 2016 - Mar 2020

  Led a group of 10-15 chemists working closely with therapeutic area leadership, biologists and cross-functional partners to identify novel targets and build a portfolio of small molecule clinical candidates for autoimmune diseases. Scientific Team Leader of projects that delivered Clinical Candidates for Psoriasis and Rheumatoid Arthritis. Founding member of the RNA Therapeutics Team. Facilitated the establishment of internal capabilities as well as an external ecosystem of… Show more Led a group of 10-15 chemists working closely with therapeutic area leadership, biologists and cross-functional partners to identify novel targets and build a portfolio of small molecule clinical candidates for autoimmune diseases. Scientific Team Leader of projects that delivered Clinical Candidates for Psoriasis and Rheumatoid Arthritis. Founding member of the RNA Therapeutics Team. Facilitated the establishment of internal capabilities as well as an external ecosystem of partnerships, capabilities, and assets for oligonucleotide-based medicines.

• Senior Research Advisor

  • Oct 2013 - Sep 2016

  Led a group of chemists, biologists and cross-functional partners to establish technologies focused on transcriptional and epigenetic regulation of gene expression. Scientific Team Leader of a project that delivered a Clinical Candidate for Osteoarthritis.

• Research Advisor

  • Oct 2007 - Sep 2013

  Chemistry Team Leader of a project that delivered a Clinical Candidate for Uterine Fibroids and projects that delivered Leads for Musculoskeletal and Metabolic Disorders.

• Principle Research Scientist

  • Jan 2004 - Sep 2007

  Scientific and technical contributions to projects that delivered Clinical Candidates for Benign Prostatic Hyperplasia and Gynecological Disorders.

• Senior Organic Chemist

  • Aug 1999 - Dec 2003



Harvard University

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Researcher

  • Aug 1997 - Aug 1999

  National Institutes of Health NRSA Postdoctoral Fellowship Synthesis of vancomycin aglycon and vancosamine National Institutes of Health NRSA Postdoctoral Fellowship Synthesis of vancomycin aglycon and vancosamine